| Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy (NCT00754091) | Procter and Gamble | 2008-06-01 |
| Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression (NCT00787501) | University of Pittsburgh | 2008-06-01 |
| IGF-1 Therapy in Patients With Cystic Fibrosis (NCT00566241) | Stony Brook University | 2008-06-01 |
| Cardiac Safety Assessment Study of Picoplatin in Solid Tumors (NCT00710697) | Poniard Pharmaceuticals | 2008-06-01 |
| A Phase I Study of BIIB015 in Relapsed/Refractory Solid Tumors (NCT00674947) | Biogen | 2008-06-01 |
| Formulation and Food Effect Study of AZD1386 in Healthy Volunteers (NCT00714337) | AstraZeneca | 2008-06-01 |
| Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor (NCT00694330) | Massachusetts General Hospital | 2008-06-01 |
| Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma (NCT00715793) | Hussein Tawbi | 2008-06-01 |
| Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines (NCT00735020) | Novartis Vaccines | 2008-06-01 |
| A Phase 1 Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic Cancer (NCT00556023) | AstraZeneca | 2008-06-01 |
| Study of Fish Oil to Reduce ALT Levels in Adolescents (NCT00694746) | Boston University | 2008-06-01 |
| Food Effect Study of a Single Dose of ZD4054 (Zibotentan) (NCT00710047) | AstraZeneca | 2008-06-01 |
| Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib (NCT00700687) | POZEN | 2008-06-01 |
| RAD001 and Lenalidomide in the Treatment of Subjects With Relapsed and Relapsed/Refractory Multiple Myeloma (NCT00729638) | Massachusetts General Hospital | 2008-06-01 |
| Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations (NCT00692055) | POZEN | 2008-06-01 |
| WS®1442 in Slightly Overweight Subjects (NCT00982501) | Dr. Willmar Schwabe GmbH & Co. KG | 2008-06-01 |
| Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors (NCT00726687) | Alaunos Therapeutics | 2008-06-01 |
| Relative Bioavailability of Single Oral Doses of Dabigatran Etexilate With or Without Oral Administration of Verapamil in Two Different Dosages in Healthy Male and Female Volunteers (NCT02171533) | Boehringer Ingelheim | 2008-06-01 |
| Cheese Intake,CLA and Hypercholesterolemia (NCT01561846) | Azienda Ospedaliera Brotzu | 2008-06-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of TA-7284 in Type 2 Diabetic Patients (NCT00707954) | Tanabe Pharma Corporation | 2008-06-01 |
| Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System Study (NCT00706784) | Massachusetts General Hospital | 2008-06-01 |
| Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer (NCT00704158) | CuraGen Corporation | 2008-06-01 |
| A Phase 1 Protocol of 5-Azacytidine and Erlotinib in Advanced Solid Tumor Malignancies (NCT00996515) | New Mexico Cancer Research Alliance | 2008-06-01 |
| Testing Strategies for Weight Loss, II (NCT00739492) | University of Pennsylvania | 2008-06-01 |
| Study to Assess Blood Levels of Itraconazole During a Two-Week Period (NCT00695071) | Stiefel, a GSK Company | 2008-06-01 |
| Esophageal Hypersensitivity Study in Healthy Volunteers (NCT00711048) | AstraZeneca | 2008-06-01 |
| AZD1386 Japanese Multiple Ascending Dosing Study (NCT00736658) | AstraZeneca | 2008-06-01 |
| Safety and Immunogenicity of 30 and 100 µg of GMZ2 in Gabonese Children Aged 1-5 Years (NCT00703066) | African Malaria Network Trust | 2008-06-01 |
| BI 10773 Administered as Oral Solution to Healthy Male Volunteers (NCT02172274) | Boehringer Ingelheim | 2008-06-01 |
| To Relieve Pain and Anxiety - an Intervention Study in Ambulance Services (NCT00792181) | Sahlgrenska University Hospital | 2008-06-01 |
| Hepatic Arterial Infusion (HAI) of Abraxane (NCT00732836) | M.D. Anderson Cancer Center | 2008-06-01 |
| Bioequivalency Study Comparing Hospira's Generic Iron Sucrose Injection to Venofer (NCT00719459) | Hospira, now a wholly owned subsidiary of Pfizer | 2008-06-01 |
| A Phase I Study of Modified Vaccinia Virus Ankara (MVA-B) in Healthy Volunteers at Low Risk of HIV Infection (NCT00679497) | Juan A. Arnaiz | 2008-06-01 |
| Islet Transplantation Through an Indwelling Catheter in the Umbilical Vein (NCT02367534) | Fuzhou General Hospital | 2008-06-01 |
| Inhaled Apocynin Decreases Reactive Oxygen Species Concentrations in Exhaled Breath Condensate in Mild Asthmatics (NCT00992667) | Medical University of Lodz | 2008-06-01 |
| Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Homeless Women (NCT00353249) | RAND | 2008-06-01 |
| Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV) (NCT00695682) | Retina Research Foundation | 2008-06-01 |
| White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmenopausal Breast Cancer Survivors (NCT00709020) | City of Hope Medical Center | 2008-06-01 |
| A Sedation/Cognition/Electroencephalogram (EEG) Study Using AZD7325 and Comparator. (NCT00720421) | AstraZeneca | 2008-06-01 |
| Drug-Drug Interaction Study of TRK-100STP (NCT00719758) | Astellas Pharma Inc | 2008-06-01 |
| Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer (NCT00706069) | Hellenic Oncology Research Group | 2008-06-01 |
| Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Butylated Hydroxytoluene and BI 54903 XX Via Respimat® Soft MistTM Inhaler B in Healthy Male Volunteers (NCT02221375) | Boehringer Ingelheim | 2008-06-01 |
| Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer (NCT00683904) | R-Pharm | 2008-06-01 |
| Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema (NCT00826618) | University of Miami | 2008-06-01 |
| Lokomat Training Effects on MS Gait Abnormalities (NCT00766272) | US Department of Veterans Affairs | 2008-06-01 |
| Study of ABT-333 in Both Healthy Volunteers and Hepatitis C Virus (HCV) + Genotype 1 Infected Subjects (NCT00696904) | AbbVie | 2008-06-01 |
| Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma (NCT00644189) | Massachusetts General Hospital | 2008-06-01 |
| A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors (NCT00721669) | ImmunoGen, Inc. | 2008-06-01 |
| Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia (NCT00709215) | OncoVista, Inc. | 2008-06-01 |
| Multi-Center Feasibility Study of Trans-oral Endoscopic Restrictive Implant System (TERIS) for Treatment of Obesity (NCT00707720) | BaroSense Inc. | 2008-06-01 |
| A Study to Assess Electrocardiogram Results in Healthy Volunteers Receiving Canagliflozin (JNJ-28431754) (NCT01787357) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2008-06-01 |
| A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054) (NCT01000818) | Merck Sharp & Dohme LLC | 2008-06-01 |
| A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress (NCT00707538) | Lantheus Medical Imaging | 2008-06-01 |
| Tobramycin Tear Concentrations (NCT00695435) | Alcon Research | 2008-06-01 |
| A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas (NCT00711191) | Hoffmann-La Roche | 2008-06-01 |
| Study Evaluating the Pharmacokinetics of Venlafaxine Extended-Release (ER) and Desvenlafaxine Succinate Sustained-Release (DVS SR) 50 mg in Healthy Subjects (NCT00727064) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-06-01 |
| Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma (NCT00701987) | Advanced Life Sciences, Inc. | 2008-06-01 |
| Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients (NCT00708916) | NYU Langone Health | 2008-06-01 |
| A Study of LY2541546 in Healthy Postmenopausal Women (NCT01742078) | Eli Lilly and Company | 2008-06-01 |
| Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (NCT00702819) | Vision Research Foundation | 2008-06-01 |
| Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects (NCT02151409) | Novo Nordisk A/S | 2008-06-01 |
| Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) (NCT00709488) | Light Sciences Oncology | 2008-06-01 |
| 8-Chloro-Adenosine in Chronic Lymphocytic Leukemia (NCT00714103) | M.D. Anderson Cancer Center | 2008-06-01 |
| Bioavailability of Dabigatran With or Without Clarithromycin in Healthy Volunteers (NCT02171585) | Boehringer Ingelheim | 2008-06-01 |
| A Study for Patients With Acute Leukemia (NCT01214655) | Eli Lilly and Company | 2008-06-01 |
| TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function. (NCT00736905) | Tibotec Pharmaceuticals, Ireland | 2008-06-01 |
| Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers (NCT00720018) | NuPathe Inc. | 2008-06-01 |
| Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors (NCT00704392) | Exelixis | 2008-06-01 |
| CD-NP in Subjects With Stable Chronic Heart Failure (NCT00620308) | Mayo Clinic | 2008-06-01 |
| Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma (NCT00698243) | Astellas Pharma Inc | 2008-06-01 |
| To Determine the Fasting Bioequivalence of Reformulated OXY Tablets Manufactured at Two Different Facilities (NCT01101321) | Purdue Pharma LP | 2008-06-01 |
| Electronic Health Technology for Assessment of Physical Activity and Eating Habits in Children and Adolescents Who Are Overweight and Those With Obesity (NCT01138293) | MEDIGREIF Inselklinik Heringsdorf | 2008-06-01 |
| Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) (NCT02231177) | Boehringer Ingelheim | 2008-06-01 |
| A Study to Assess the Safety and Pharmacokinetics of a Single Intravenous Administration of CNTO 328 Derived From 2 Different Cell Lines in Healthy Participants (NCT02074800) | Centocor, Inc. | 2008-06-01 |
| IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101) (NCT00785122) | Immatics Biotechnologies GmbH | 2008-06-01 |
| Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis (NCT01909778) | Boehringer Ingelheim | 2008-06-01 |
| Safety, Tolerability and Pharmacokinetics of Repeat Doses of GSK1014802. (NCT00908154) | Biogen | 2008-05-31 |
| Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer (NCT00684294) | Mary Crowley Medical Research Center | 2008-05-27 |
| Single Dose Escalation Study FTIM in Order to Assess Safety and Tolerability of GSK610677 (NCT00694902) | GlaxoSmithKline | 2008-05-26 |
| A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese Subjects (NCT01597609) | GlaxoSmithKline | 2008-05-22 |
| Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth (NCT00685503) | National Eye Institute (NEI) | 2008-05-21 |
| Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel Growth (NCT00685854) | National Eye Institute (NEI) | 2008-05-21 |
| A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects. (NCT00671216) | GlaxoSmithKline | 2008-05-20 |
| Positron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time. (NCT00945503) | GlaxoSmithKline | 2008-05-19 |
| Lithium Treatment for Patients With Spinocerebellar Ataxia Type I (NCT00683943) | National Institute of Neurological Disorders and Stroke (NINDS) | 2008-05-18 |
| A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation (NCT00670423) | Jennifer E. Schwartz | 2008-05-16 |
| GSK706769 Repeat Dose Study (NCT00711386) | GlaxoSmithKline | 2008-05-16 |
| Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects (NCT00808093) | GlaxoSmithKline | 2008-05-12 |
| AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer (NCT01445418) | National Cancer Institute (NCI) | 2008-05-12 |
| Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients (NCT00780702) | National Institute on Drug Abuse (NIDA) | 2008-05-08 |
| An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate) (NCT00875784) | GlaxoSmithKline | 2008-05-06 |
| A Healthy Volunteer Study With Inhaled GSK573719 and Placebo (NCT00803673) | GlaxoSmithKline | 2008-05-05 |
| Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects (NCT00743405) | GlaxoSmithKline | 2008-05-02 |
| Single-Blind, Placebo-Controlled, Randomized Study Testing Single Ascending Doses Of GSK369796 In Healthy Subjects (NCT00675064) | GlaxoSmithKline | 2008-05-02 |
| Study of the Effect of Neck Treatment on Shoulder Impingement (NCT00764764) | CAMC Health System | 2008-05-01 |
| Far Infrared Irradiation for Managing, Control and Treatment of Huntington's Disease (HD) (NCT00675077) | GAAD Medical Research Institute Inc. | 2008-05-01 |
| Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze (NCT00634504) | BTG International Inc. | 2008-05-01 |
| Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer (NCT00677612) | Tokyo University | 2008-05-01 |
| Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma (NCT00691652) | OHSU Knight Cancer Institute | 2008-05-01 |
| Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer (NCT00877253) | Samyang Biopharmaceuticals Corporation | 2008-05-01 |